Skip to content

Dietary Factors and Disfluency: A Look Into Food Allergies and Other Environmental Triggers Associated With Variations in Severity of Vocal Cord Tension.

Dietary Factors and Disfluency. A Look Into Causes and Variations in Severity of Disfluency in Regards to Vocal Cord Tension.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02547051
Enrollment
10
Registered
2015-09-11
Start date
2018-01-31
Completion date
2022-02-28
Last updated
2017-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysfluency Developmental, Vocal Cord Tension

Brief summary

The purpose of this study is to see whether participants with persistent developmental disfluency who report fluctuational disfluency due to vocal cord tension on a day to day basis of can achieve a more normalized fluency by identifying dietary allergen responses and subsequently eliminating these dietary triggers from their daily consumption.

Interventions

OTHERFood Allergy Testing and Elimination Diet

Food allergy testing and elimination diet

Sponsors

The R2 Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients reporting persistent developmental disfluency.

Exclusion criteria

* Patients reporting no changes in disfluency severity or frequency

Design outcomes

Primary

MeasureTime frameDescription
Dietary Factors and Disfluency: Variations in Severity of Vocal Cord tension1 YearInitial fluency samples are taken prior to treatment protocol of study. Food sensitivity panel will be assessed for potential allergans. Allergan responses are graded from 0 being no response to food allergen to 3 being the strongest response and subsequent removal of sensitive allergan from diet. Speech sample and disfluency severity will be evaluated qualitatively again via the SSI-3 on repeat office visit at fixed interval scale. Erickson S-24 repeated at end of study and final conclusions made.

Countries

United States

Contacts

Primary ContactYohan R, Medical Doctor
yohanrr@auamed.net9174096426

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026